World Heart Day- Revisiting Metoprolol's Contribution to Cardiology
This month, on September 29, 2024, as we celebrate World Heart Day, lets dive into the contribution of an age-old and trusted molecule Metoprolol, in the field of cardiology. Just last month, in August 2024, we marked the 46th anniversary of Metoprolol's approval.
Metoprolol has remained a resourceful pharmacological agent in cardiology practice in India. It has stood the test of scientific excellence, with robust real-world experience, and remains a valuable life-saving agent.
Joining us in today's discussion at the Medical Dialogues Show, we have with us Dr. Dilip Kumar, Senior Consultant Interventional Cardiologist and Electrophysiologist, Director of Cardiac Cath Lab, and Chief Academic Coordinator at Medica Institute of Cardiac Sciences.
He shares his insights on:
1. What are your thoughts on the robust legacy of Metoprolol in cardiology?
2. Which indications would you like to consider Metoprolol in cardiology?
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.